Helicobacter spp. and Related Organisms

Principles and Practice of Clinical Bacteriology: Second Edition

Volumn , Issue , 2006, Pages 473-483

  Jenks, Peter J ^a  

^a DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

Cytotoxin associated gene A (CagA) and cag pathogenicity island; Genome, genomics and genetic diversity; H. pylori eradication therapies; helicobacter species and human disease; helicobacter spp. and related organisms

Indexed keywords

EID: 84861618767     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470017968.ch40     Document Type: Chapter

References (138)

1. Alm RA, Ling LS, Moir DT et al. (1999) Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature, 397, 176-180
2. Appelmelk BJ, Simoons-Smit I, Negrini R et al. (1996) Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infection and Immunity, 64, 2031-2040
3. Appelmelk BJ, Shiberu B, Trinks C et al. (1998) Phase variation in Helicobacter pylori lipopolysaccharide. Infection and Immunity, 66, 70-76
4. Asahi M, Azuma T, Ito S et al. (2000) Helicobacter pylori CagA can be tyrosine phosphorylated in gastric epithelial cells. The Journal of Experimental Medicine, 191, 593-602
5. Atherton JC, Cao P, Peek RM et al. (1995) Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific vacA types with cytotoxin production and peptic ulceration. The Journal of Biological Chemistry, 270, 1771-1777
6. Barnard FM, Loughlin MF, Fainberg HP et al. (2004) Global regulation of virulence and the stress response by CsrA in the highly adapted human gastric pathogen Helicobacter pylori. Molecular Microbiology, 51, 15-32
7. Beier D and Frank R (2000) Molecular characterization of two-component systems of Helicobacter pylori. Journal of Bacteriology, 182, 2068-2076
8. Bereswill S, Waidner U, Odenbreit S et al. (1998) Structural, functional and mutational analysis of the pfr gene encoding a ferritin from Helicobacter pylori. Microbiology, 144, 2505-2516
9. Bina JE, Alm RA, Uria-Nickelsen M et al. (2000) Helicobacter pylori uptake and efflux: basis for intrinsic susceptibility to antibiotics in vitro. Antimicrobial Agents and Chemotherapy, 44, 248-254
10. Blaser MJ (1990) Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. The Journal of Infectious Diseases, 161, 626-633
11. Boneca IG, de Reuse H, Epinat JC et al. (2003) A revised annotation and comparative analysis of Helicobacter pylori genomes. Nucleic Acids Research, 31, 1704-1714
12. Cederbrant G, Kahlmeter G and Ljungh A (1993) The E test for antimicrobial susceptibility testing of Helicobacter pylori. The Journal of Antimicrobial Chemotherapy, 31, 65-71
13. Censini S, Lange C, Xiang Z et al. (1996) cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proceedings of the National Academy of Sciences of the United States of America, 93, 14648-14653
14. Colland F, Rain JC, Gounon P et al. (2001) Identification of the Helicobacter pylori anti-sigma28 factor. Molecular Microbiology, 41, 477-487
15. Covacci A, Censini S, Bugnoli M et al. (1993) Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proceedings of the National Academy of Sciences of the United States of America, 90, 5791-5795
16. Covacci A, Telford JL, Del Giudice J et al. (1999) Helicobacter pylori virulence and genetic geography. Science, 284, 1328-1333
17. Cover TL, Tummuru MK, Cao P et al. (1994) Divergence of genetic sequences for the vacoulating cytotoxin among Helicobacter pylori strains. The Journal of Biological Chemistry, 269, 10566-10573
18. Crabtree JE, Taylor JD, Wyatt JI et al. (1991) Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet, 338, 332-335
19. Dailidiene D, Bertoli MT, Miciuleviciene J et al. (2002) Emergence of tetracycline resistance in Helicobacter pylori: multiple mutational changes in 16S ribosomal DNA and other genetic loci. Antimicrobial Agents and Chemotherapy, 46, 3940-3946
20. De Ungria MC, Kolesnikow T, Cox PT and Lee A (1999) Molecular characterization and interstrain variability of pHPS1, a plasmid isolated from the Sydney Strain (SS1) of Helicobacter pylori. Plasmid, 41, 97-109
21. Delany I, Spohn G, Rappuoli R and Scarlato V (2001) The Fur repressor controls transcription of iron-activated and-repressed genes in Helicobacter pylori. Molecular Microbiology, 42, 1297-1309
22. Dhaenens L, Szczebara F and Husson MO (1997) Identification, characterization and immunogenicity of the lactoferrin-binding protein from Helicobacter pylori. Infection and Immunity, 65, 514-518
23. Doig P, de Jonge BL, Alm RA et al. (1999) Helicobacter pylori physiology predicted from genomic comparison of two strains. Microbiology and Molecular Biology Reviews, 63, 675-707
24. Dore MP, Graham DY and Sepulveda AR (1999) Different penicillin-binding profiles in amoxicillin-resistant Helicobacter pylori. Helicobacter, 4, 154-161
25. Dunn BE, Campbell GP, Pérez-Pérez GI and Blaser MJ (1990) Purification and characterization of urease from Helicobacter pylori. The Journal of Biologicalhemistry, 265, 3464-3469
26. Dunn BE, Cohen H and Blaser MJ (1997) Helicobacter pylori. Clinical Microbiology Reviews, 10, 720-741
27. Dytoc M, Gold B, Louie M et al. (1993) Comparison of Helicobacter pylori and attaching-effacing Escherichia coli adhesion to eukaryotic cells. Infection and Immunity, 61, 448-456
28. Eaton KA and Krakowka S (1994) Effect of gastric pH on urease-dependent colonization of gnotobiotic piglets by Helicobacter pylori. Infection and Immunity, 62, 3604-3607
29. Eaton KA, Suerbaum S, Josenhans C and Krakowka S (1996) Colonization of gnotobiotic piglets by Helicobacter pylori deficient in two flagellin genes. Infection and Immunity, 64, 2445-2448
30. Evans DJ, Evans DG, Takemura T et al. (1995) Characterization of a Helicobacter pylori neutrophil-activating protein. Infection and Immunity, 63, 2213-2220
31. Fiocca R, Necchi V, Sommi P et al. (1999) Release of Helicobacter pylori vacuolating cytotoxin by both a specific secretion pathway and budding of outer membrane vesicles. Uptake of released toxin and vesicles by gastric epithelium. The Journal of Pathology, 188, 220-226
32. Fischer W, Püls J, Buhrdorf R et al. (2001) Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Molecular Microbiology, 42, 1337-1348
33. Foryst-Ludwig A and Naumann M (2000) PAK1 activates the NIK-IKK NF-kappaB pathway and proinflammatory cytokines in H. pylori-infection. The Journal of Biological Chemistry, 275, 39779-39785
34. Frazier BA, Pfeifer JD, Russell DG et al. (1993) Paracrystalline inclusions of a novel ferritin containing nonheme iron, produced by the human gastric pathogen Helicobacter pylori: evidence for a third class of ferritins. Journal of Bacteriology, 175, 966-972
35. Frenck RW and Clemens J (2003) Helicobacter in the developing world. Microbes and Infection, 5, 705-713
36. Fujikawa A, Shirasaka D, Yamamoto S et al. (2003) Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori. Nature Genetics, 33, 375-381
37. Geis G, Suerbaum S, Forstoff B et al. (1993) Ultrastructure and biochemical studies of the flagellar sheath of Helicobacter pylori. Journal of Medical Microbiology, 38, 371-377
38. Gerrits MM, Schuijffel D, van Zwet AA et al. JG (2002) Alterations in penicillin-binding protein 1A confer resistance to beta-lactam antibiotics in Helicobacter pylori. Antimicrobial Agents and Chemotherapy, 46, 2229-2233
39. Goodwin A, Kersulyte D, Sisson G et al. (1998) Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase. Molecular Microbiology, 28, 383-393
40. Goodwin CS and Armstrong JA (1990) Microbiological aspects of Helicobacter pylori (Campylobacter pylori). European Journal of Clinical Microbiology, 9, 1-13
41. Goodwin CS, Armstrong JA and Marshall BJ (1986) Campylobacter pyloridis, gastritis and peptic ulceration. Journal of Clinical Pathology, 39, 353-365
42. Goodwin CS, Armstrong JA, Chilvers T et al. (1989) Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen. nov. as Helicobacter pylori comb. nov. and Helicobacter mustelae comb. nov. respectively. International Journal of Systematic Bacteriology, 39, 397-405
43. Harris AG, Wilson JE, Danon SJ et al. (2003) Catalase (KatA) and KatAassociated protein (KapA) are essential to persistent colonization in the Helicobacter pylori SS1 mouse model. Microbiology, 149, 665-672
44. Hatakeyama M (2003) Helicobacter pylori CagA-a potential bacterial oncoprotein that functionally mimics the mammalian Gab family of adaptor proteins. Microbes and Infection, 5, 143-150
45. Hessey SJ, Spencer J, Wyatt JI et al. (1990) Bacterial adhesion and disease activity in Helicobacter-associated chronic gastritis. Gut, 31, 134-138
46. Higashi H, Tsutsumi R, Fujiyata A et al. (2002) Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proceedings of the National Academy of Sciences of the United States of America, 99, 14428-14433
47. Houben MH, Van De Beek D, Hensen EF et al. (1999) A systematic review of Helicobacter pylori eradication therapy-the impact of antimicrobial resistance on eradication rates. Alimentary Pharmacology & Therapeutics, 13, 1047-1055
48. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1994) Helicobacter pylori. In Schistosomes, Liver Flukes, and Helicobacter pylori: Views and Expert Opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. International Agency for Research on Cancer, Lyon, pp. 177-240.
49. Ilver D, Arnqvist A, Ögren J et al. (1998) Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science, 279, 373-377
50. Jenks PJ (2002) Causes of failure of eradication of Helicobacter pylori. British Medical Journal, 325, 3-4
51. Jenks PJ, Ferrero RL and Labigne A (1999) The role of the rdxA gene in the evolution of metronidazole resistance in Helicobacter pylori. The Journal of Antimicrobial Chemotherapy, 43, 753-758
52. Jeong JY, Mukhopadhyay AK, Dailidiene D et al. (2000) Sequential inactivation of rdxA (HP0954) and frxA (HP0642) nitroreductase genes causes moderate and high-level metronidazole resistance in Helicobacter pylori. Journal of Bacteriology, 182, 5082-5090
53. Josenhans C, Niehus E, Amersbach S et al. (2002) Functional characterization of the antagonistic flagellar late regulators FliA and FlgM of Helicobacter pylori and their effects on the H. pylori transcriptome. Molecular Microbiology, 43, 307-322
54. Jungblut PR, Bumann D, Haas G et al. (2000) Comparative proteome analysis of Helicobacter pylori. Molecular Microbiology, 36, 710-725
55. Kavermann H, Burns BP, Angermüller K et al. (2003) Identification and characterization of Helicobacter pylori genes essential for gastric colonization. The Journal of Experimental Medicine, 197, 813-822
56. Kelly DJ (1998) The physiology and metabolism of the human gastric pathogen Helicobacter pylori. Advances in Microbial Physiology, 40, 137-189
57. Kersulyte D, Chalkauskas H and Berg DE (1999) Emergence of recombinant strains of Helicobacter pylori during human infection. Molecular Microbiology, 31, 31-43
58. Kusters JG, Gerrits MM, Strijp JA and Vandenbrouke-Grauls CM (1997) Coccoid forms of Helicobacter pylori are the morphological manifestation of cell death. Infection and Immunity, 65, 3672-3679
59. Kwon DH, Kato M, El-Zaatari FA et al. (2000) Frame-shift mutations in NAD(P)H flavin oxidoreductase encoding gene (frxA) from metronidazole resistant Helicobacter pylori ATCC43504 and its involvement in metronidazole resistance. FEMS Microbiology Letters, 188, 197-202
60. Kwon DH, Dore MP, Kim JJ et al. (2003) High-level beta-lactam resistance associated with multidrug resistance in Helicobacter pylori. Antimicrobial Agents and Chemotherapy, 47, 2169-2178
61. Labigne A and Jenks PJ (2001) Mutagenesis. In Helicobacter pylori: Physiology and Genetics. Mobley HL, Mendz GL and Hazell SL (eds). American Society for Microbiology, Washington, DC, pp. 335-344.
62. Labigne A, Cussac V and Courcoux P (1991) Shuttle cloning and nucleotide sequence of Helicobacter pylori genes responsible for urease activity. Journal of Bacteriology, 173, 1920-1931
63. Leong RW and Sung JJ (2002) Helicobacter species and hepatobiliary disease. Alimentary Pharmacology & Therapeutics, 16, 1037-1045
64. Leunk RD, Johnson PT, David BC et al. (1988) Cytotoxin activity in broth-culture filtrates of Campylobacter pylori. Journal of Medical Microbiology, 26, 93-99
65. Lim RK (1920) A parasitic spiral organism in the stomach of the cat. Parasitology, 12, 108-112
66. Loughlin MF, Barnard FM, Jenkins D et al. (2003) Helicobacter pylori mutants defective in RuvC Holliday junction resolvase display reduced macrophage survival and spontaneous clearance from the murine gastric mucosa. Infection and Immunity, 71, 2022-2031
67. Mahdavi J, Sondén B, Hurtig M et al. (2002) Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science, 297, 573-578
68. Malfertheiner P, Mégraud F, O'Morain C et al. (2002) Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Alimentary Pharmacology & Therapeutics, 16, 167-180
69. Marais A, Mendz GL, Hazell SL and Mégraud F (1999) Metabolism and genetics of Helicobacter pylori: the genomic era. Microbiology and Molecular Biology Reviews, 63, 642-674
70. Marshall BJ (1983) Unidentified curved bacilli on gastric epithelium in chronic active gastritis. Lancet, i, 1273-1275
71. Marshall BJ, Armstrong JA, McGechie DB and Glancy RJ (1985) Attempt to fulfill Koch's postulates for pyloric Campylobacter. The Medical Journal of Australia, 142, 436-439
72. McGee DJ, Radcliff FJ, Mendz GL et al. (1999) Helicobacter pylori rocF is required for arginase activity and acid protection in vitro but is not essential for colonization of mice or for urease activity. Journal of Bacteriology, 181, 7314-7322
73. McGowan CC, Necheva AS, Forsyth MH et al. (2003) Promoter analysis of Helicobacter pylori genes with enhanced expression at low pH. Molecular Microbiology, 48, 1225-1239
74. Mégraud F (1998) Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori. Gastroenterology, 115, 1278-1282
75. Mégraud F, Lehn N, Lind T et al. (1999) Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH2 study. Antimicrobial Agents and Chemotherapy, 43, 2747-2752
76. Merrell DS, Goodrich ML, Otto G et al. (2003) pH-regulated gene expression of the gastric pathogen Helicobacter pylori. Infection and Immunity, 71, 3529-3539
77. Molinari M, Salio M, Galli C et al. (1998) Selective inhibition of li-dependent antigen processing by Helicobacter pylori toxin VacA. The Journal of Experimental Medicine, 187, 135-140
78. Monteiro MA, Chan KH, Rasko DA et al. (1998) Simultaneous expression of type 1 and type 2 Lewis blood group antigens by Helicobacter pylori lipopolysaccharides. The Journal of Biological Chemistry, 273, 11533-11543.
79. Moran AP (1996) The role of lipopolysaccharide in Helicobacter pylori pathogenesis. Alimentary Pharmacology & Therapeutics, 10 (Suppl. 1), 39-50
80. Muotiala A, Helander IM, Pyhälä L et al. (1992) Low biological activity of Helicobacter pylori lipopolysaccharide. Infection and Immunity, 60, 1714-1716
81. National Committee for Clinical Laboratory Standards (1999) Performance Standards for Antimicrobial Susceptibility Testing-Ninth Informational Supplement: Document M100-S9. National Committee for Clinical Laboratory Standards, Villanova, PA.
82. Naumann M, Wessler S, Bartsch C et al. (1999) Activation of activator protein 1 and stress response kinases in epithelial cells colonized by Helicobacter pylori encoding the cag pathogenicity island. The Journal of Biological Chemistry, 274, 31655-31662
83. Nedenskov-Sorensen P, Bukholm G and Bovre K (1990) Natural competence for genetic transformation in Campylobacter pylori. The Journal of Infectious Diseases, 161, 365-366
84. Negrini R, Lisato L, Zanella I et al. (1991) Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. Gastroenterology, 101, 437-445
85. Odenbreit S, Till M, Hofreuter D et al. (1999) Genetic and functional characterization of the alpAB gene locus essential for the adhesion of Helicobacter pylori to human gastric tissue. Molecular Microbiology, 31, 1537-1548
86. Odenbreit S, Püls J, Sedlmaier B et al. (2000) Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science, 287, 1497-1500
87. Olson JW and Maier RJ (2002) Molecular hydrogen as an energy source for Helicobacter pylori. Science, 298, 1788-1790
88. Pagliaccia C, de Bernard M, Lupetti P et al. (1998) The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity Proceedings of the National Academy of Sciences of the United States of America, 95, 10212-10217
89. Papini E, de Bernard M, Milia E et al. (1994) Cellular vacuoles induced by Helicobacter pylori originate from late endosomal compartments Proceedings of the National Academy of Sciences of the United States of America, 91, 9720-9724
90. Papini E, Satin B, Norais N et al. (1998) Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pylori vacuolating cytotoxin. The Journal of Clinical Investigation, 102, 813-820
91. Parsonnet J, Friedman GD, Vandersteed DP et al. (1991) Helicobacter pylori infection and the risk of gastric cancer. The New England Journal of Medicine, 325, 1127-1129
92. Parsonnet J, Hansen S, Rodriguez L et al. (1994) Helicobacter pylori infection and gastric lymphoma. The New England Journal of Medicine, 330, 1267-1271
93. Parsonnet J, Shmuely H and Haggerty T (1999) Fecal and oral shedding of Helicobacter pylori from healthy infected adults. Journal of the American Medical Association, 282, 2240-2245
94. Pawlowski K, Zhang B, Rychlewski L and Godzik A (1999) The Helicobacter pylori genome: from sequence analysis to structural and functional predictions Proteins, 36, 20-30
95. Peek RM (2003) Intoxicated cells and stomach ulcers. Nature Genetics, 33, 328-330
96. Phadnis SH, Parlow MH, Levy M et al. (1996) Surface localization of Helicobacter pylori urease and a heat shock protein homolog requires bacterial autolysis. Infection and Immunity, 64, 905-912
97. Prinz C, Hafsi N and Voland P (2003) Helicobacter pylori virulence factors and the host immune response: implications for therapeutic vaccination Trends in Microbiology, 11, 134-138
98. Puls J, Fischer W and Haas R (2002) Activation of Helicobacter pylori CagA by tyrosine phosphorylation is essential for dephosphorylation of host cell proteins in gastric epithelial cells. Molecular Microbiology, 43, 961-969
99. Rain JC, Selig L, De Reuse H et al. (2001) The protein-protein interaction map of Helicobacter pylori. Nature, 409, 211-215
100. Ramarao N, Gary-Owen SD and Meyer TF (2000) Helicobacter pylori induces but survives the extracellular release of oxygen radicals from professional phagocytes using its catalase activity. Molecular Microbiology, 38, 103-113
101. Rohde M, Püls J, Buhrdorf R et al. (2003) A novel sheathed surface organelle of the Helicobacter pylori cag type IV secretion system. Molecular Microbiology, 49, 219-234
102. Rosenow EC and Sandford AH (1915) The bacteriology of ulcer of the stomach and duodenum in man. The Journal of Infectious Diseases, 17, 210-226
103. Rupnow MF, Owens DK, Shachter R and Parsonett J (1999) Helicobacter pylori vaccine development and use: a cost-effectiveness analysis using the Institute of Medicine Methodology. Helicobacter, 4, 272-280
104. Salama NR, Otto G, Tompkins L and Falkow S (2001) Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection. Infection and Immunity, 69, 730-736
105. Salomon H (1896) Ueber das spirillum des saugetiermagens und sein verhalten zu den gelegzellen. Zentralblatt fur Bakteriologie, 19, 433-441
106. Segal ED, Cha J, Lo J et al. (1999) Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proceedings of the National Academy of Sciences of the United States of America, 96, 14559-14564
107. Selbach M, Moese S, Hauch CR et al. (2002) Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. The Journal of Biological Chemistry, 277, 6775-6778
108. Skouloubris S, Labigne A and DeReuse H (1997) Identification and characterization of an aliphatic amidase of Helicobacter pylori. Molecular Microbiology, 25, 989-998
109. Skouloubris S, Thiberge JM, Labigne A and Reuse HD (1998) The Helicobacter pylori UreI protein is not involved in urease activity but is essential for bacterial survival in vivo. Infection and Immunity, 66, 4517-4521
110. Solnick JV and Schauer DB (2001) Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases. Clinical Microbiology Reviews, 14, 59-97
111. Spohn G and Scarlato V (1999) The autoregulatory HspR repressor protein governs chaperone gene transcription in Helicobacter pylori. Molecular Microbiology, 34, 663-674
112. Steer HW (1975) Ultrastructure of cell migration through the gastric epithelium and its relationship to bacteria. Journal of Clinical Pathology, 28, 639-646
113. Stein M, Rappuoli R and Covacci A (2000) Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation Proceedings of the National Academy of Sciences of the United States of America, 97, 1263-1268
114. Stein M, Bagnoli F, Halenbach R et al. (2002) c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Molecular Microbiology, 43, 971-980
115. Suerbaum S and Josenhans C (1999) Virulence factors of H. pylori: implications for vaccine development. Molecular Medicine Today, 5, 32-39
116. Suerbaum S, Smith JM, Bapumia K et al. (1998) Free recombination within Helicobacter pylori. Proceedings of the National Academy of Sciences of the United States of America, 95, 12619-12624
117. Telford JL, Ghiara P, Dell'Orco M et al. (1994) Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. The Journal of Experimental Medicine, 179, 1653-1658
118. Thompson LJ and de Reuse H (2002) Genomics of Helicobacter pylori Helicobacter, 7 (Suppl. 1), 1-7.
119. Thompson LJ, Merrell DS, Neilan BA et al. (2003) Gene expression profiling of Helicobacter pylori reveals a growth-phase-dependent switch in virulence gene expression. Infection and Immunity, 71, 2643-2655
120. Tomb JF, White O, Kervalage AR et al. (1997) The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature, 388, 539-547
121. Tombola F, Morbiato L, Del Giudice G et al. (2001) The Helicobacter pylori VacA toxin is a urea permease that promotes urea diffusion across epithelia. The Journal of Clinical Investigation, 108, 803-804
122. Toracchio S, Cellini L, Di Campli E et al. (2000) Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication Alimentary Pharmacology & Therapeutics, 14, 1639-1643
123. Trieber CA and Taylor DE (2002) Mutations in the 16S rRNA genes of Helicobacter pylori mediate resistance to tetracycline. Journal of Bacteriology, 184, 2131-2140
124. Van der Wouden EJ, Thijs JC, van Zwet AA et al. (1999) The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole containing anti-Helicobacter pylori regimens: a meta-analysis. The American Journal of Gastroenterology, 94, 1751-1759
125. van Vliet AH, Poppelaars SW, Davies BJ et al. (2002) NikR mediates nickelresponsiveness transcriptional induction of urease expression in Helicobacter pylori. Infection and Immunity, 70, 2846-2852
126. Versalovic J, Shortridge D, Kibler K et al. (1996) Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrobial Agents and Chemotherapy, 40, 477-480
127. Viala J, Chaput C, Boneca IG et al. (2003) Nod1-dependent proinflammatory responses to Helicobacter pylori infection in gastric epithelial cells Gastroenterology, 124 (Suppl. 1), A-43.
128. Voland P, Weeks DL, Marcus EA et al. (2003) Interactions among the seven Helicobacter pylori proteins encoded by the urease gene cluster. American Journal of Physiology. Gastrointestinal and Liver Physiology, 284G 96-G106.
129. Wang G, Humayun MZ and Taylor DE (1999) Mutation as an origin of genetic variability in Helicobacter pylori. Trends in Microbiology, 7, 488-493
130. Warren JR (1983) Unidentified curved bacilli on gastric epithelium in chronic active gastritis. Lancet, i, 1273-1275.
131. Weeks DL, Eskandari S, Scott DR and Sachs G (2000) A H +-gated urea channel: the link between Helicobacter pylori urease and gastric colonization Science, 287, 482-485
132. Worst DJ, Otto BR and Graaf J (1995) Iron-repressible outer membrane proteins of Helicobacter pylori involved in heme uptake. Infection and Immunity, 63, 4161-4165
133. Yahiro K, Niidome T, Kimura M et al. (1999) Activation of Helicobacter pylori VacA toxin by alkaline or acid conditions increases its binding to a 250-kDa receptor protein-tyrosine phosphatase beta. The Journal of Biological Chemistry, 274, 36693-36699
134. Ye D, Willhite DC and Blanke SR (1999) Identification of the minimal intracellular vacuolating domain of the Helicobacter pylori vacuolating cytotoxin The Journal of Biological Chemistry, 274, 9277-9282
135. Yoshida N, Granger DN, Evans DJ et al. (1993) Mechanisms involved in Helicobacter pylori-induced inflammation. Gastroenterology, 105, 1431-1440
136. Young GO, Stemmet N, Lastovica A et al. (1992) Helicobacter pylori lipopolysaccharide stimulates gastric mucosal pepsinogen secretion. Alimentary Pharmacology & Therapeutics, 6, 169-177
137. Zevering Y, Jacob L and Meyer TF (1999) Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development Gut, 45, 465-474
138. Zheng PW and Jones NL (2003) Helicobacter pylori strains expressing the vacuolating cytotoxin interrupt phagosome maturation in macrophages by recruiting and retaining TACO (coronin 1) protein. Cellular Microbiology, 5, 25-40